Blue Capital Reinsurance Holdings (NYSE:BCRH) has been downgraded from Outperform to Mkt Perform in a statement by Raymond James earlier today.
- Updated: October 19, 2016
Boasting a price of $18.10, Blue Capital Reinsurance Holdings (NYSE:BCRH) traded -2.73% lower on the day. With the last close up -0.76% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Blue Capital Reinsurance Holdings has recorded a 50-day average of $18.00 and a two hundred day average of $17.74. Volume of trade was up over the average, with 31,563 shares of BCRH changing hands over the typical 21,334
Raymond James has downgraded Blue Capital Reinsurance Holdings (NYSE:BCRH) from Outperform to Mkt Perform in a statement released on 10/19/2016.
With a total market value of $0, Blue Capital Reinsurance Holdings has price-earnings ratio of 9.23 with a one year low of $16.46 and a one year high of $19.51 .
More About Blue Capital Reinsurance Holdings (NYSE:BCRH)
Blue Capital Reinsurance Holdings Ltd. provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company conducts its operations through its subsidiaries, including Blue Capital Re Ltd. (Blue Capital Re), which provides collateralized reinsurance, and Blue Capital Re ILS Ltd. (Blue Capital Re ILS), which conducts hedging and other investment activities. Blue Capital Re provides reinsurance to third-party insurance and reinsurance companies through reinsurance contracts, either directly with the cedant or on a fronted basis. Blue Capital Re ILS may purchase catastrophe bonds to access certain risks. Blue Capital Re or Blue Capital Re ILS may buy and sell industry loss warranties as a way to access certain risks. Blue Capital Re ILS' portfolio may include over-the-counter or exchange-traded futures or options listed on catastrophe indexes, such as catastrophe or weather derivatives.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.